Attached files
| file | filename |
|---|---|
| 10-K - Sonoma Pharmaceuticals, Inc. | v224652_10k.htm |
| EX-31.2 - Sonoma Pharmaceuticals, Inc. | v224652_ex31-2.htm |
| EX-31.1 - Sonoma Pharmaceuticals, Inc. | v224652_ex31-1.htm |
| EX-23.1 - Sonoma Pharmaceuticals, Inc. | v224652_ex23-1.htm |
| EX-10.52 - Sonoma Pharmaceuticals, Inc. | v224652_ex10-52.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Oculus Innovative Sciences, Inc., a California corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The annual report on Form 10-K for the year ended March 31, 2011 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: June 3, 2011
|
/s/ Hojabr Alimi
|
|
|
Hojabr Alimi
|
|
|
Chief Executive Officer and Principal Executive Officer
|
|
|
/s/ Robert E. Miller
|
|
|
Robert E. Miller
|
|
|
Chief Financial Officer, Principal Financial Officer and
|
|
|
Principal Accounting Officer
|